TY - JOUR
AU - Faksova, K.
AU - Walsh, D.
AU - Jiang, Y.
AU - Griffin, J.
AU - Phillips, A.
AU - Gentile, A.
AU - Kwong, J.
AU - Macartney, K.
AU - Naus, M.
AU - Grange, Zoe
AU - Escolano, S.
AU - Sepulveda, G.
AU - Shetty, Arvind
AU - Pillsbury, A.
AU - Sullivan, Christopher
AU - Naveed, Z.
AU - Janjua, N.
AU - Giglio, N.
AU - Perälä, N.
AU - Nasreen, S.
AU - Gidding, H.
AU - Hovi, P.
AU - Vo, T.
AU - Cui, F.
AU - Deng, Lul Lojok
AU - Cullen, L.A.
AU - Artama, M.
AU - Lu, H.
AU - Clothier, H.
AU - Batty, K.
AU - Paynter, J.
AU - Petousis-Harris, H.
AU - Buttery, J.
AU - Black, S.
AU - Hviid, A.
PY - 2024
DA - February
TI - COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals
JO - Vaccine
DO - https://doi.org/10.1016/j.vaccine.2024.01.100
AB - BackgroundThe Global COVID Vaccine Safety (GCoVS) Project, established in 2021 under the multinational Global Vaccine Data Network™ (GVDN®), facilitates comprehensive assessment of vaccine safety. This study aimed to evaluate the risk of adverse events of special interest (AESI) following COVID-19 vaccination from 10 sites across eight countries.
PB - Elsevier
KW - Coronavirus (COVID-19)
KW - Immunisation and screening
ER